Search for: "LaBelle v. LaBelle"
Results 21 - 40
of 12,157
Sorted by Relevance
|
Sort by Date
21 Jun 2024, 9:05 pm
In its recent case, FDA v. [read post]
13 Nov 2019, 9:15 am
In Celltrion, Inc. v. [read post]
9 Apr 2013, 11:00 am
Wilson v. [read post]
12 Jan 2016, 12:10 pm
Colquitt v. [read post]
21 Apr 2015, 8:51 am
EAR would be a significant step towards this goal, as replacing the ad hoc CBE process for label changes with a single procedure for all drugs backed by FDA mandate would overturn Levinerather than Mensing and allow preemption to clear most of the lawyers (on both sides of the “v. [read post]
18 May 2016, 4:30 am
Today’s case, Tangney v. [read post]
15 May 2008, 9:34 am
We care because, at least since the Supreme Court's decision in Thompson v. [read post]
14 Oct 2021, 4:15 am
The Federal Circuit’s recent majority opinion and Chief Judge Prost’s dissenting opinion in the GlaxoSmithKline LLC v. [read post]
31 Oct 2013, 11:34 am
” In Bohac v. [read post]
28 Oct 2014, 10:57 am
The claim in United States v. [read post]
25 Aug 2016, 12:00 am
(See the NRDC report the Dating Game for an inventory of states’ labeling laws.)In the case of United States v. [read post]
19 Mar 2015, 5:00 am
Garcia v. [read post]
15 May 2023, 10:14 am
USA, Inc. v. [read post]
17 Apr 2017, 5:23 am
Facts: This products liability case (Ruggiero v. [read post]
17 Apr 2017, 5:23 am
Facts: This products liability case (Ruggiero v. [read post]
14 Jan 2014, 11:23 am
And now Mississippi joins the growing number of courts that have said Class III medical device claims are preempted, regardless of whether the device was put to an off-label use.The case is Ledet v. [read post]
27 Jul 2012, 12:40 pm
” United States v. [read post]
30 Oct 2023, 1:39 pm
Mier v. [read post]
4 Mar 2009, 7:04 am
The ruling came in the case of Wyeth v. [read post]
25 Jul 2013, 5:00 am
Ct. 2466 (2013), and PLIVA v. [read post]
